Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Hans, Verbaan"'
Autor:
Olav Dalgard, Michelle Martinot-Peignoux, Hans Verbaan, Kristian Bjøro, Helmer Ring-Larsen, Patrick Marcellin
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0120866 (2015)
The aim of this study was to determine in patients with HCV genotype 2 or 3 the performance at week 4 of two assays with different sensitivities for HCV RNA detection, for the prediction of SVR and stratification for treatment duration (14 and 24 wee
Externí odkaz:
https://doaj.org/article/431d0c2ca5fe41d7a2269d9905295e38
Autor:
Ola Weiland, Maria Castedal, Olav Dahlgard, Henrik Gjertsen, Malin Ackefors, Hans Verbaan, Annika Wernerson
Publikováno v:
Infectious Diseases. 47:209-217
Relapse of hepatitis C virus (HCV) infection after liver transplantation (LT) is universal. Tolerance for treatment with pegylated-interferon (peg-IFN) and ribavirin (RBV) is suboptimal and withdrawals due to adverse events frequent. We sought to imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35024d01c7ce14ff2413db8feabad64
https://doi.org/10.3109/00365548.2014.984322
https://doi.org/10.3109/00365548.2014.984322
Autor:
Benedikte Bjøro, Håvard Midgard, Olav Dalgard, Hans Verbaan, Tone Rustøen, Milada Cvancarova Småstuen
Publikováno v:
Journal of advanced nursing. 74(3)
Aims To evaluate hope in hepatitis C patients 9 years after curative treatment with pegylated interferon and ribavirin. Background Successful treatment of hepatitis C leads to improved quality of life in responders compared with non-responders. The l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ce9366d60b1a46737c6049e8dc5708
https://pubmed.ncbi.nlm.nih.gov/29082540
https://pubmed.ncbi.nlm.nih.gov/29082540
Autor:
Fredrik Rorsman, Hanns-Ulrich Marschall, Mårten Werner, Emma Nilsson, Ola Weiland, Annika Bergquist, Åsa Danielsson Borssén, Stergios Kechagias, Hans Verbaan, Nils Nyhlin
Publikováno v:
Scandinavian journal of gastroenterology. 52(9)
Epidemiological studies of autoimmune hepatitis (AIH) show varying figures on prevalence and incidence, and data on the long-term prognosis are scarce. Objective To investigate the epidemiology, long-term prognosis and causes of death in a Swedish AI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d260bff8878919176ed14538f9191cf
https://pubmed.ncbi.nlm.nih.gov/28562110
https://pubmed.ncbi.nlm.nih.gov/28562110
Autor:
Hanns-Ulrich Marschall, Annika Bergquist, Hans Verbaan, Ola Weiland, Nils Nyhlin, Åsa Danielsson Borssén, Stergios Kechagias, Emma Nilsson, Richard Palmqvist, Mårten Werner, Fredrik Rorsman
Publikováno v:
Medicine
Autoimmune hepatitis (AIH) is a chronic autoimmune liver disease that if left untreated may lead to the development of cirrhosis. Previous studies on AIH patients have suggested that fibrosis and even cirrhosis can be reversed by medical treatment. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f89ac35f481033c5e51ccb43414a83d
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-335251
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-335251
Autor:
Hans, Verbaan, Per, Sangfelt
Publikováno v:
Lakartidningen. 113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19f18c5aa46ce34812852320f131694e
https://pubmed.ncbi.nlm.nih.gov/26978807
https://pubmed.ncbi.nlm.nih.gov/26978807
Autor:
Mina Meshkat, Erik Hertervig, Anders Gustavsson, Per Karlén, Per M. Hellström, Curt Tysk, Gottfried Novacek, Harald Vogelsang, Clemens Dejaco, Walter Reinisch, Andrea Walch, Hans Verbaan, Anders Magnuson, Gunnar Järnerot, Magnus Ström, Mogens Vilien, Christer Grännö, S. Angelberger, Lars Blomquist, Mats Sjöberg, Ingalill Friis-Liby, Jonas Halfvarson
Publikováno v:
Inflammatory Bowel Diseases. 18:212-218
Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives. Methods: Outcome of rescue therapy w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128600846c5887b1adf5010f99fac678
https://doi.org/10.1002/ibd.21680
https://doi.org/10.1002/ibd.21680
Autor:
Anders Magnuson, Gunnar Järnerot, Anders Gustavsson, Magnus Ström, Christer Grännö, Curt Tysk, Per M. Hellström, Mogens Vilien, Per Karlén, Lars Blomquist, Hans Verbaan, Erik Hertervig, Ingalill Friis-Liby, Jonas Halfvarson
Publikováno v:
Alimentary Pharmacology & Therapeutics. 32:984-989
P>Background The long-term efficacy of infliximab as rescue therapy in steroid-refractory ulcerative colitis is not well described. Aim To examine the long-term efficacy of infliximab as a rescue therapy through a 3-year follow-up of a previous place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e142d6dc0b319d32d5f8596e7ae160a7
https://doi.org/10.1111/j.1365-2036.2010.04435.x
https://doi.org/10.1111/j.1365-2036.2010.04435.x
Autor:
Angelo Andriulli, Valeria Piazzolla, Massimiliano Copetti, D. Bacca, Hans Verbaan, Vito Carretta, Helmer Ring-Larsen, O. Dalgard, Alessandra Mangia, Raffaele Cozzolongo, Leonardo Mottola, Nicola Minerva
Publikováno v:
Alimentary Pharmacology & Therapeutics. 31:1346-1353
Aliment Pharmacol Ther 31, 1346–1353 Summary Background The optimal dose of ribavirin to be used in combination with Peg-IFN in patients with HCV genotypes 2 and 3 undergoing short treatment has not been established. Aim To explore the relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc99c16c244e8c8bffc30582121489f1
https://doi.org/10.1111/j.1365-2036.2010.04290.x
https://doi.org/10.1111/j.1365-2036.2010.04290.x
Autor:
Ulf Hindorf, Mårten Werner, Sven Almer, Hans Verbaan, Einar Björnsson, Sven Wallerstedt, Hanne Prytz, Khatoon Jahed, Rolf Olsson, Carsten Peterson, Annika Bergquist
Publikováno v:
Journal of Hepatology. 52:106-111
BACKGROUND & AIMS: Corticosteroids alone or in conjunction with azathioprine (AZA) is the standard treatment in autoimmune hepatitis (AiH). Individual variations in thiopurine (TP) metabolism may affect both drug efficacy and toxicity. Our aim was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cbf49c9a15c88c17b6271653ffb19b
https://doi.org/10.1016/j.jhep.2009.10.004
https://doi.org/10.1016/j.jhep.2009.10.004